Hypoxia-Inducible Factor-1 Promotes Pancreatic Ductal Adenocarcinoma Invasion and Metastasis by Activating Transcription of the Actin-Bundling Protein Fascin
Published version of a preprint
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Because of the early onset of local invasion and distant metastasis, pancreatic ductal adenocarcinoma (PDAC) is the most lethal human malignant tumor, with a 5-year survival rate of less than 5%. In this study, we investigated the role of fascin, a prometastasis actin-bundling protein, in PDAC progression, invasion, and the molecular mechanisms underlying fascin overexpression in PDAC. Our data showed that the expression levels of fascin were higher in cancer tissues than in normal tissues, and fascin overexpression correlated with the PDAC differentiation and prognosis. Fascin overexpression promoted PDAC cell migration and invasion by elevating matrix metalloproteinase-2 (MMP-2) expression. Fascin regulated MMP-2 expression through protein kinase C and extracellular signal—regulated kinase. Importantly, our data showed that hypoxia induced fascin overexpression in PDAC cells by promoting the binding of hypoxia-inducible factor-1 (HIF-1) to a hypoxia response element on the fascin promoter and transactivating fascin mRNA transcription. Intriguingly, HIF-1α expression levels in PDAC patient specimens significantly correlated with fascin expression. Moreover, immunohistochemistry staining of consecutive sections demonstrated colocalization between HIF-1α and fascin in PDAC specimens, suggesting that hypoxia and HIF-1α were responsible for fascin overexpression in PDAC. When ectopically expressed, fascin was able to rescue PDAC cell invasion after HIF-1α knockdown. Our results demonstrated that fascin is a direct target gene of HIF-1. Our data suggested that the hypoxic tumor microenvironment in PDAC might promote invasion and metastasis by inducing fascin overexpression, and fascin might be targeted to block PDAC progression. Cancer Res; 74(9); 2455–64. ©2014 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it was recently found that HIF-1α is overexpressed in pancreatic cancer even under normoxia condition and levels of HIF-1α are positively correlated with tumor progression, angiogenesis, cell migration and poor prognosis [7, 8, 10, 11].”
From Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma (2015) · cites this paper as [7]
In the citing paper
“HIF-1α is an important transcription factor for tumor growth, invasion, angiogenesis, metabolism and drug resistance [7, 10, 25].”
From Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma (2015) · cites this paper as [7]
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676 · cited 1×
“Hypoxia-inducible factor-1 (HIF-1; consists of highly regulated HIF-1a and a constitutively expressed HIF-1b) is the most important transcription factor as a result of intratumoral hypoxia, which can mediate many adaptive physiologic responses (3).”
BackgroundHypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
American Association for Cancer Research
Salgaller, M. L. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1413 · Cited by 473
Fascins, and their roles in cell structure and function
Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N., & Adams, J. C. (2002) · BioEssays · doi:10.1002/bies.10070 · Cited by 328
Li, A., Dawson, J. C., Forero-Vargas, M., Spence, H. J., Yu, X., König, I., Anderson, K., & Machesky, L. M. (2010) · Current Biology · doi:10.1016/j.cub.2009.12.035 · Cited by 309
Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology
Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., van Heek, T., Ashfaq, R., Meyer, R., Walter, K., Berg, K., Hollingsworth, M. A., Cameron, J. L., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62551-5 · Cited by 294
Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?
Hashimoto, Y., Skacel, M., & Adams, J. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.004 · Cited by 275 · cited 1×
“It is possible that the binding of active PKC to fascin enhanced the phosphorylation of PKC substrates such as Raf-1 to promote cancer cell proliferation (35).”
BackgroundMigrastatin analogues target fascin to block tumour metastasis
Chen, L., Yang, S., Jakoncic, J., Zhang, J. J., & Huang, X.-Y. (2010) · Nature · doi:10.1038/nature08978 · Cited by 268
Self-citation
Research works printed but not linked: 1
- Hashimoto, 2005, Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?, Int J Biochem Cell Biol, 37, 1787, 10.1016/j.biocel.2005.05.004 · DOI · Paper page
Cited by
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., Wu, X., Ma, J., Zhou, M., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0928-4 · Cited by 1,457
“Moreover, the invasion and metastasis of tumor cells are promoted by altering the expression of E-cadherin, N-cadherin, Snail, and vimentin, which are all EMT markers [123, 124].”
BackgroundThe role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
Tumor Microenvironment and Differential Responses to Therapy
Hirata, E., & Sahai, E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026781 · Cited by 422
“This can be problematic because HIF1-regulated transcriptional programs are linked to increased invasion and epithelial to mesenchymal transition (Zhao et al. 2014; El-Naggar et al. 2015).”
BackgroundNRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378
“For example, Hif1a, an important transcription factor that mediates adaptive responses to intratumoral hypoxia and malignant progression in PDA (Zhao et al., 2014), was markedly decreased in Nrf2-deficient Kras mutant cells.”
Zhao, X., Li, F., Li, Y., Wang, H., Ren, H., Chen, J., Nie, G., & Hao, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.028 · Cited by 247
Self-citation
Metadata
- Authors
- Zhao, X., Gao, S., Ren, H., Sun, W., Zhang, H., Sun, J., Yang, S., & Hao, J.
- Affiliations
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Venue
- Cancer Research
- Published
- 2014-04-30
- Volume
- 74
- Issue
- 9
- Pages
- 2455-2464
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2127513469
- Cited by
- 163
- References
- 43
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 13 · 2023: 11 · 2022: 18 · 2021: 18 · 2020: 13 · 2019: 17 · 2018: 12 · 2017: 16 · 2016: 16 · 2015: 13 · 2014: 8
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- pancreatic ductal adenocarcinoma, fascin, hypoxia-inducible factor-1α, tumor invasion, metastasis, actin bundling, MMP-2, protein kinase C, extracellular signal-regulated kinase, hypoxia response element, transcriptional regulation, tumor hypoxia, cell migration, prognosis
- MeSH terms
- Aged, Binding Sites, Carrier Proteins, Female, Humans, Male, Microfilament Proteins, Middle Aged, Neoplasm Invasiveness, Pancreatic Neoplasms, Promoter Regions, Genetic, Transcriptional Activation, Gene Expression, Gene Expression Regulation, Neoplastic, Response Elements, Matrix Metalloproteinase 2, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, Kaplan-Meier Estimate, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia-Inducible Factor-1 Promotes Pancreatic Ductal Adenocarcinoma Invasion and Metastasis by Activating Transcription of the Actin-Bundling Protein Fascin. https://app.cochat.ai/papers/10.1158/0008-5472.can-13-3009
- The paper
- Zhao, X., Gao, S., Ren, H., Sun, W., Zhang, H., Sun, J., Yang, S., & Hao, J. (2014). Hypoxia-Inducible Factor-1 Promotes Pancreatic Ductal Adenocarcinoma Invasion and Metastasis by Activating Transcription of the Actin-Bundling Protein Fascin. Cancer Research. https://doi.org/10.1158/0008-5472.can-13-3009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.